Comparison Results
Swedish Orphan Biovitrum AB
―
$264.19B
110.43
4 Buy
1 Hold
0 Sell
Strong Buy
Hansa Biopharma AB
kr43.30
kr4.12B
-5.15
37.01%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
MX:SOBIN
Swedish Orphan Biovitrum AB
―
―
―
SE:HNSA
Hansa Biopharma AB
40.50
11.00
37.29%
SE:MVIR
Medivir AB
1.82
-0.11
-5.60%
SE:ORX
Orexo AB
13.28
-13.17
-49.79%
SE:NEWBRY
Newbury Pharmaceuticals AB
2.50
-0.09
-3.47%
SE:DICOT
Dicot Pharma AB
0.25
-0.50
-67.02%